En Carta Diagnostics
About:
En Carta Diagnostics is a state-of-the-art molecular testing platform.
Website: https://www.encarta.bio/
Top Investors: CentraleSupélec Venture
Description:
En Carta Diagnostics is a state-of-the-art molecular testing platform that focuses on development of healthcare molecular diagnostics tools from the field of synthetic biology.
Total Funding Amount:
1.5M EUR
Headquarters Location:
Paris, Ile-de-France, France
Founded Date:
2022-01-01
Founders:
Number of Employees:
1-10
Last Funding Date:
2024-05-22
IPO Status:
Private
Industries:
© 2025 bioDAO.ai